6-(1-methylpyrazol-4-yl)-3-(2-thienyl)imidazo[1,2-b]pyridazine

ID: ALA3732078

Chembl Id: CHEMBL3732078

PubChem CID: 90480124

Max Phase: Preclinical

Molecular Formula: C14H11N5S

Molecular Weight: 281.34

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1cc(-c2ccc3ncc(-c4cccs4)n3n2)cn1

Standard InChI:  InChI=1S/C14H11N5S/c1-18-9-10(7-16-18)11-4-5-14-15-8-12(19(14)17-11)13-3-2-6-20-13/h2-9H,1H3

Standard InChI Key:  NLDBRPSBWKLECG-UHFFFAOYSA-N

Associated Targets(Human)

GRK5 Tchem G protein-coupled receptor kinase 5 (1126 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Grk5 G protein-coupled receptor kinase 5 (36 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Scyl1 N-terminal kinase-like protein (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Beta-TC6 (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
C2C12 (756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 281.34Molecular Weight (Monoisotopic): 281.0735AlogP: 2.86#Rotatable Bonds: 2
Polar Surface Area: 48.01Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.58CX LogP: 2.46CX LogD: 2.46
Aromatic Rings: 4Heavy Atoms: 20QED Weighted: 0.57Np Likeness Score: -2.93

References

1.  (2014)  Nitrogen bicyclic compounds as inhibitors for Scyl1 and Grk5, 

Source